Structure-permeation relations of met-enkephalin peptide analogues on absorption and secretion mechanisms in Caco-2 monolayers

被引:32
作者
Lang, VB
Langguth, P
Ottiger, C
WunderliAllenspach, H
Rognan, D
RothenRutishauser, B
Perriard, JC
Lang, S
Biber, J
Merkle, HP
机构
[1] ETH ZURICH, SWISS FED INST TECHNOL, DEPT PHARM, CH-8057 ZURICH, SWITZERLAND
[2] ETH ZURICH, SWISS FED INST TECHNOL, INST CELL BIOL, CH-8057 ZURICH, SWITZERLAND
[3] UNIV ZURICH, INST PHYSIOL, CH-8057 ZURICH, SWITZERLAND
关键词
D O I
10.1021/js960387x
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Due to the low effective permeabilities of peptides at many absorption sites, their structure-permeation relations are of high interest. In this work structure-permeation relations of Met-enkephalin analogues are presented using confluent Caco-2 cells as an in vitro permeation model. Four model peptides (Met-enkephalin, [D-Ala(2)]Met-enkephalin, [D-Ala(2)]Met-enkephalinamide, and metkephamid) were tested in terms of permeability, lipophilicity, charge, and molecular size, Permeability coefficients (P-eff) across Caco-2 cells were low, 3.3 x 10(-8) to 9.5 x 10(-8) cm s(-1), and were similar to typical paracellular markers. No correlation of permeability and the log(apparent octanol/buffer partition coefficient) was observed. A 40-fold increase of the permeability of metkephamid in the presence of 10 mM EDTA suggested a significant contribution of paracellular transport Independent support for this conclusion was obtained by visualizing the pathway of the fluorescein isocyanate isomer I 1-metkephamid by confocal laser scanning microscopy (CLSM). The fluorophore-labeled peptide was observed in the intercellular space only. Metkephamid permeabilities were found to be direction-specific, Permeabilities from basolateral to apical (b-to-a) were significantly higher (ca. 4-fold) than in the opposite (a-to-b) direction. The addition of verapamil equalized the permeabilities in the a-to-b and b-to-a directions, suggesting the involvement of a P-glycoprotein-mediated secretion mechanism. Similar observations were obtained with [D-Ala(2)]-Met-enkephalinamide but not with Met-enkephalin and [D-Ala(2)]Met-enkephalin. In contrast to the other analogues, metkephamid and [D-Ala(2)]Met-enkephalinamide are positively charged at neutral pH, as demonstrated by their isoelectric points (pi 8.6 for [D-Ala(2)]Met-enkephalinamide and metkephamid and 5.3 for [D-Ala(2)]Met-enkephalin and Met-enkephalin). The data is in agreement with the literature showing that most compounds secreted by the P-glycoprotein transporter carry a positive charge.
引用
收藏
页码:846 / 853
页数:8
相关论文
共 50 条
[41]  
TEORELL TORSTEN, 1938, BIO CHEM ZEITSCHR, V299, P416
[42]   CELLULAR-LOCALIZATION OF THE MULTIDRUG-RESISTANCE GENE-PRODUCT P-GLYCOPROTEIN IN NORMAL HUMAN-TISSUES [J].
THIEBAUT, F ;
TSURUO, T ;
HAMADA, H ;
GOTTESMAN, MM ;
PASTAN, I ;
WILLINGHAM, MC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) :7735-7738
[43]   ROLE OF P-GLYCOPROTEIN IN DOLASTATIN-10 RESISTANCE [J].
TOPPMEYER, DL ;
SLAPAK, CA ;
CROOP, J ;
KUFE, DW .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (03) :609-612
[44]   FLUORESCAMINE - REAGENT FOR ASSAY OF AMINO-ACIDS, PEPTIDES, PROTEINS, AND PRIMARY AMINES IN PICOMOLE RANGE [J].
UDENFRIEND, S ;
STEIN, S ;
BOHLEN, P ;
DAIRMAN, W .
SCIENCE, 1972, 178 (4063) :871-+
[45]   Evidence for intestinal secretion as an additional clearance pathway of talinolol enantiomers: Concentration- and dose-dependent absorption in vitro and in vivo [J].
Wetterich, U ;
SpahnLangguth, H ;
Mutschler, E ;
Terhaag, B ;
Rosch, W ;
Langguth, P .
PHARMACEUTICAL RESEARCH, 1996, 13 (04) :514-522
[46]  
WIDDICOMBE JH, 1988, METHODS BRONCHIAL MU
[47]   TRANSPORT AND PERMEABILITY PROPERTIES OF HUMAN CACO-2 CELLS - AN INVITRO MODEL OF THE INTESTINAL EPITHELIAL-CELL BARRIER [J].
WILSON, G ;
HASSAN, IF ;
DIX, CJ ;
WILLIAMSON, I ;
SHAH, R ;
MACKAY, M ;
ARTURSSON, P .
JOURNAL OF CONTROLLED RELEASE, 1990, 11 (1-3) :25-40
[48]  
WOODCOCK S, 1991, J CELL SCI, V98, P323
[49]  
YU CD, 1979, J PHARM SCI, V68, P1347
[50]  
ZHOU XH, 1994, J CONTROL RELEASE, V29, P239